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Abstract
Viral capsid dynamics are often observed during infectious events such as cell surface attachment,
entry and genome release. Structural analysis of adeno-associated virus (AAV), a helper-
dependent parvovirus, revealed a cluster of surface-exposed tyrosine residues at the icosahedral
two-fold symmetry axis. We exploited the latter observation to carry out selective oxidation of Tyr
residues, which yielded crosslinked viral protein (VP) subunit dimers, effectively “stitching”
together the AAV capsid two-fold interface. Characterization of different Tyr-to-Phe mutants
confirmed that the formation of crosslinked VP dimers is mediated by dityrosine adducts and
requires the Tyr704 residue, which crosses over from one neighboring VP subunit to the other.
When compared to unmodified capsids, Tyr-crosslinked AAV displayed decreased transduction
efficiency in cell culture. Surprisingly, further biochemical and quantitative microscopy studies
revealed that restraining the two-fold interface hinders externalization of buried VP N-termini,
which contain a phospholipase A2 domain and nuclear localization sequences critical for
infection. These adverse effects caused by tyrosine oxidation support the notion that interfacial
dynamics at the AAV capsid two-fold symmetry axis play a role in externalization of VP N-
termini during infection.
Conformational changes in the non-enveloped capsids of adenovirus and rotavirus have been
associated with critical events during infection (1, 2, 3, 4). Similarly, rearrangements of viral
protein (VP) subunits have been postulated in the case of parvoviruses subsequent to cell
entry (5, 6, 7). Adeno-associated viruses are small, helper-dependent parvoviruses
packaging a 4.7kb ssDNA genome (8). The single-layered, T=1 icosahedral shell is
assembled from three overlapping viral proteins (VPs), VP1, VP2 and VP3, which are
generated from overlapping reading frames in the cap gene. A total of 60 copies of VP1
(87kDa), VP2 (72kDa) and VP3 (62kDa) (Figure 1A) in a predicted ratio of 1:1:10 form the
AAV capsid (9, 10, 11). The overlapping VP3 amino acids, which share the same C-
terminal amino acid sequence with VP1/VP2 subunits, contain the molecular determinants
for receptor binding, tissue tropism, and antigenicity.
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The VP1 subunit contains an extended N-terminal unique domain (VP1u) that displays
phospholipase A2 (PLA2) activity. In addition, the extended VP1/VP2 subunits contain a
common region that contains a cluster of positively charged motifs comprised of basic
amino acid residues, which have been implicated in assembly, intracellular trafficking and
nuclear entry of AAV serotype 2 (AAV2) vectors (12, 13, 14). Externalization of the AAV2
VP1u domain, which remains buried within the capsid prior to cellular uptake, is essential
for endosomal escape and subsequent nuclear entry (5, 13, 15, 16). However, insights into
the structural and cellular mechanisms that trigger this event have remained elusive.
Structural studies of different AAV serotypes have revealed that the characteristic surface
features on AAV capsids are formed by variable loop regions located between eight β-
strands in each monomer subunit (17, 18, 19, 20, 21). These studies have also established
that inter-subunit interactions at the two-fold and five-fold icosahedral symmetry axis are
more conserved than those utilized for three-fold interactions. Further, calculations of buried
surface areas between AAV capsid subunit monomers at different interfaces show that inter-
subunit interactions are least prevalent at the two-fold interface and most extensive at the
three-fold symmetry axis (18). In the current report, we have utilized a chemical approach,
which involves covalent crosslinking of adjacent tyrosine residues (22), to interrogate AAV
capsid dynamics. Owing to the clustering of tyrosine residues at the two-fold interface of
AAV2 capsids, this chemical strategy effectively “stitched” capsid protein subunits together,
resulting in decreased conformational flexibility. Crosslinked capsids demonstrate
attenuated externalization of the VP1u domain and decreased transduction efficiency in
vitro. The studies described herein corroborate a critical role for conformational changes at
the two-fold interface in VP1u domain externalization and efficient transduction of AAV
vectors.
RESULTS AND DISCUSSION
Tyrosine cluster at the two-fold interface
Phosphorylation of surface-exposed tyrosine residues in VP subunits has been shown to
target AAV capsids for proteasomal degradation (23). In these studies, mutation of surface-
exposed tyrosines to phenylalanines reduced ubiquitination of VP subunits and enhanced
AAV2 transduction by varying levels. Amongst these residues, Tyr700, Tyr704 and Tyr730
are clustered within a single polypeptide loop at the two-fold symmetry axis. The two-fold
interface located between VP dimers is the weakest region on the icosahedral AAV capsid
and is comprised of a single polypeptide loop (W694-N705) derived from each neighboring
VP subunit (18). A surface rendering of two neighboring VP trimers is shown within the
context of the AAV2 capsid (Figure 1B). As seen in Figure 1C, a close up view of the dimer
of trimers reveals different surface-exposed tyrosine residues in each neighboring VP
subunit (red or blue) with Y700/Y704/Y730 clustering together at the two-fold interface
(white border). The Y704 residue extending from each VP monomer into the neighboring
subunit is highlighted (white arrows). These structural attributes provided the rationale for
exploring tyrosine-specific crosslinking chemistries as a strategy to selectively constrain
conformational changes at the two-fold symmetry axis.
Tyrosine crosslinking yields VP dimers
Oxidative tyrosine crosslinking has previously been utilized as a tool to probe the
multimeric structure of proteins such as RNase (24) and the bacteriophage Qβ (22). The
underlying chemistry involves use of nickel(II) salts to mediate the crosslinking of proteins
in the presence of a free radical source. Once oxidized, the Ni(III) ion, stabilized by a short
Gly-Gly-His tripeptide, extracts an electron from a solvent accessible tyrosine to give a
tyrosyl radical that can be captured by a neighboring phenolic side chain, giving dityrosine
Horowitz et al. Page 2













units (24, 25) (Figure 2A). We postulated that this covalent crosslinking of tyrosine residues
within the AAV capsid, which are clustered predominantly near the two-fold interface,
would selectively restrain potential conformational changes that occur at that interface.
Upon crosslinking under optimal reaction conditions (22), we observed inter-subunit VP
dimers of different molecular weights (MW) as determined by western blot analysis with the
B1 monoclonal antibody (MAb), which recognizes all three VP subunits (Figure 2B). As
shown in Figure 2B, premixing the chemical reagents was suboptimal due to the formation
of capsid protein precipitates, which were not resolved by electrophoresis. In contrast, the
sequential addition of MMPP to Ni/GGH in the presence of AAV2 particles provided
optimal reaction conditions for crosslinked VP dimer formation. Although we observed
some crosslinking in the absence of oxidant, this effect was completely abolished when a
reducing agent (L-Cysteine) was added (data not shown). This might suggest the presence of
an adventitious oxidant in the reaction. No inter-capsid crosslinking was observed under
these optimal conditions as demonstrated by the absence of capsid aggregates in electron
micrographs (Supplementary Figure S1). Further, no significant loss of viral titer was
observed due to crosslinking (Supplementary Table S2). In addition to protein bands that
correspond to VP1, VP2 and VP3 monomer subunits, higher MW protein bands were
identified as VP1–VP3 (146kDa), VP2–VP3 (134kDa), and VP3-VP3 (124kDa) dimers
(Figure 2B). Due to the ~10-fold lower levels of VP1/VP2 subunits relative to the VP3
subunit alone, we were only able to observe additional VP1-VP1 (168kDa) and VP1–VP2
(157kDa) dimers when using A1/A69 MAbs, which recognize the VP1/VP2 N-terminal
domain (26) (Figure 2C & 2D). The VP2-VP2 dimers (144kDa) were likely
indistinguishable from VP1–VP3 dimers (146kDa). Densitometric analysis of VP subunit
bands visualized by colloidal blue® staining indicates that dimers containing at least one
VP3 subunit constitute the major crosslinked species and that ~50% of VP subunits on the
capsid are crosslinked to form dimers (Figure 2E & 2F).
Tyr704 mediates formation of crosslinked VP dimers
In order to determine which residues are involved in the formation of crosslinked VP
dimers, we used site-directed mutagenesis to mutate Tyr residues to Phe, which is inert to
Ni(II)-mediated chemical modification (22). Based on structural cues described earlier
(Figure 1B), we generated Tyr-to-Phe mutations at positions 700, 704, and 730 (VP1
numbering), all of which cluster together at the two-fold interface. As mentioned earlier,
these residues were previously modified by Srivastava and others (23). Consistent with these
previous reports, AAV2 mutants Y700F, Y704F, and Y730F packaging a chicken β-actin
promoter-driven luciferase (CBA-Luc) transgene cassette yielded viral titers comparable to
unmodified AAV2 vectors (Supplementary Table S2).
The Tyr-to-Phe mutants were subjected to crosslinking and different VP subunits analyzed
using western blot analysis using B1 and A1 MAbs as described earlier. As seen in Figure
3A, each Tyr-to-Phe mutant displayed markedly different crosslinking efficiency in
comparison with wild type AAV2 capsids. Notably, the Y700F mutant demonstrated robust
crosslinking as indicated by the decreased intensity of protein bands corresponding to VP
monomer subunits as well as higher MW VP dimers. In contrast, the Y704F mutation
completely abolished crosslinking as evidenced by the lack of higher MW VP dimers. These
observations are further corroborated by western blot analysis with the A1 MAb, which
detects the VP1u region (Figure 3B). The Y730F mutant is not recognized by the B1 MAb,
since Y730 lies within the the B1 epitope, but displayed significant crosslinking efficiency
as evidenced by A1 MAb staining shown in Figure 3B. These results corroborate the notion
that crosslinked VP dimers are indeed formed due to dityrosine adducts at the two-fold
interface. Further, crosslinked AAV2 vectors displayed gene transfer efficiency (luciferase
transgene expression levels) approximately 1 log unit lower than their unmodified
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counterparts in HEK 293 cells at 24hrs post-transduction (Figure 3C). The mutants Y700F
and Y730F show a similar decrease in transduction efficiency (~ 1 log unit) after
crosslinking, consistent with western blot analysis. In contrast, gene transfer efficiency of
the Y704F mutant only shows a slight decrease (<2-fold) upon crosslinking, confirming the
absence of crosslinked VP subunit dimers. These results are further supported by measuring
the distances between the 3′ carbon atoms on different tyrosine residues. As seen in Figure
3D, the inter-subunit distances are 10Å, 13Å and 21Å between Y704 and Y730, Y700 and
Y704 respectively. These observations suggest that the formation of inter-subunit dityrosine
adducts is most likely due to free radical crosslinking of the Tyr704 residue in one VP
subunit with either Y700 or Y730 residues in the neighboring subunit (Figure 3D).
Crosslinking blocks VP1u domain externalization
Prior to infection, the AAV2 VP1u domain reported to be buried within the capsid interior
and is thus inaccessible to the A1 antibody (5, 6). Externalization of the VP1u domain,
which has been shown to possess phospholipase A2 (PLA2) activity and nuclear localization
signals, is critical for endosomal escape and nuclear entry of AAV vectors (12, 13, 14).
Several reports have demonstrated that the VP1u domain is externalized upon limited heat
shock and that conformational changes that lead to this irreversible event are blocked in
certain AAV capsid five-fold mutants (5, 6). Externalization of the VP1u domain was
determined through immunoblot analysis with the A1 MAb, which detects residues 123–130
in the VP1 N-terminal region along with the A20 MAb, which detects a conformational
epitope maintained only in intact AAV2 capsids as an internal standard (26). Both
unmodified and crosslinked AAV2 capsids were heated to different temperatures and
immunoblots quantitated using densitometric analysis (Figure 4). Loss of A20 recognition,
which correlates with disruption of tertiary and quaternary structure of both unmodified and
crosslinked AAV2 capsids begins at ~55 °C (Figure 4A). In contrast, externalization of the
VP1u domain, as evidenced by a gain in A1 recognition beginning at ~60 °C, is observed
only with unmodified AAV2, but not tyrosine-crosslinked capsids (Figure 4B). Overall,
these observations support the notion that conformational restraint at the two-fold interface
blocks externalization of the VP1u domain.
Confocal microscopy studies have been utilized to determine intracellular trafficking defects
of various AAV mutants (12, 13, 14). Using confocal immunofluorescence microscopy, we
observed similar intracellular trafficking patterns, characterized by perinuclear accumulation
for both unmodified and crosslinked AAV2 vectors at 20hrs post-infection in HeLa cells
(Figure 5A & 5D). Immunostaining of the VP1u (amino acids 2–16) domain with an anti-
VP1u MAb (14) shows co-localization of exposed VP1u with A20 immunostaining for
unmodified AAV2 capsids (Figure 5B & 5C). In contrast, crosslinked capsids show low
levels of exposed VP1u domains (Figure 5E & 5F). The mean VP1u fluorescence intensity
(red signal) normalized to the mean capsid fluorescence intensity (green signal) per cell
were calculated using ImageJ® software. Histograms of normalized fluorescence intensities
for unmodified and crosslinked AAV2 capsids are shown in Figure5G and 5H, respectively.
Approximately 15% of the cells transduced with unmodified AAV2 capsids are observed at
low peak intensity (0.1) and an additional 15% at higher peak intensity (0.4) (Figure 5G). In
contrast, nearly twice as many cells (~30%) transduced with crosslinked AAV2 capsids are
observed at low peak intensity (0.1) and only 5% with higher peak intensity (0.4) (Figure
5H). The latter results confirm that plasticity of the two-fold interface is essential for
exposure of the buried VP1u domain during intracellular trafficking of AAV2 virions.
Further, these results provide insight into the putative mechanism underlying decreased
transduction efficiency of tyrosine-crosslinked AAV2 virions in vitro (Figure 3C).
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Mechanisms of VP1 N-terminal domain exposure
The VP1 N-terminal region is not ordered in electron density maps of different parvoviral
capsid structures, plausibly due to low abundance of VP1 subunits and/or their asymmetric
arrangement within the capsid (9). However, it is well known that the icosahedral two-fold
constitutes the weakest interface in the AAV capsid (17, 18). Moreover, a recent structural
study with AAV8 capsids at different pH values revealed a further decrease (~5%) in
association energy and buried surface area at the two-fold interface under acidic conditions
(27). Thus, it is likely that buried VP N-termini are externalized through openings at the
two-fold interface as opposed to their extrusion through the five-fold pore (Figure 6), as
postulated earlier (5). Such a mechanism is consistent with the observation that generation
of inter-subunit dityrosine crosslinks, which would stitch together the two-fold interface,
hinders externalization of VP N-termini resulting in decreased transduction efficiency of
crosslinked AAV virions in cell culture.
Alternatively, it is possible that constraining the two-fold interface also restricts structural
transitions required to open the five-fold pore. Previous studies with MVM have shown that
the five symmetry-related copies of a conserved leucine residue, located at the base of each
pentamer, appear to form a portal resembling an iris diaphragm at the base of each pore (7).
Mutation of this conserved leucine appears to exert a destabilizing effect on MVM capsids
resulting in premature exposure of VP1 N-termini. In contrast, similar mutagenesis studies
carried out in AAV2 capsids report a decrease in pore flexibility, which prevents VP1u
domain exposure (6, 12). Although the structures of AAV and MVM capsid five-fold pores
are markedly different, it is interesting to note that mutation of residues positioned around
the base or on the inner wall of the cylindrical pore exerts a deleterious effect on VP1u
domain exposure in both parvoviruses (6, 28). Thus, constraining the AAV capsid two-fold
depression could indeed alter the flexibility of the pentamer interface, which in turn is likely
to block opening of the iris-like, five-fold pore (Figure 6B). Further high resolution
structural studies are required to understand the exact mechanism of VP1u domain
externalization in parvoviruses. Nevertheless, the current studies provide new insight into




The crystal structure of the AAV2 VP3 monomer (PDB ID: 1lp3) (17) was used as a
template for modeling studies. Models of the AAV capsid (60 VP3 subunits) and trimers
were obtained using the oligomer generator tool in the VIPERdb2 database (29)
(http://viperdb.scripps.edu/). Surface rendered and cartoon models of capsid subunits were
generated using the program PyMol (The PyMOL Molecular Graphics System, Schrödinger
LLC, http://www.pymol.org/).
Cells and plasmids
Adherent human embryonic kidney (HEK293) and HeLa cells were grown at 37 °C in 5%
CO2 with Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum and 1%
penicillin/streptomycin/amphotericin B (MediaTech). Plasmids pXR2 (AAV2 helper
containing Rep and Cap genes) and pXX6-80 (Adenovirus helper genes) were obtained from
the UNC Vector Core. The pTR-CBA-Luc packaging construct containing chicken-beta
actin (CBA) promoter-driven firefly luciferase transgene (Luc) has been described earlier
(30).
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Generation of AAV2 capsid mutants
The plasmid pXR2 was utilized as a template for site-directed mutagenesis to generate
Y700F, Y704F, and Y730F mutations in the surface loop region of each VP subunit located
near the two-fold depression. All mutagenesis reactions using different oligonucleotide
primers (IDT) (Supplementary Table S1), were carried out as per manufacturer instructions
outlined in the Quikchange XL® site-directed mutagenesis kit (Agilent Technologies).
Individual clones were sequenced at the UNC Genome Analysis facility and capsid
sequences analyzed using VectorNTI® software (Invitrogen).
Virus production and characterization
Recombinant AAV2 vectors packaging the CBA-Luc cassette were produced in HEK293
cells using the triple plasmid transfection method (31) At 60hrs post-transfection, cells were
harvested and processed using cesium chloride gradient followed by sucrose gradient
ultracentrifugation and dialysis. Viral titers were determined by quantitative PCR in a Roche
Lightcycler® with primers specific for the Luc transgene region (Supplementary Table S1).
Chemical crosslinking of AAV capsids
Viral capsids (~1×1010 vector genomes) were crosslinked using 10mM Ni/GGH and 10mM
magnesium monoperoxyphthalate (MMPP) (Sigma-Aldrich). Ni/GGH was prepared by
combining equal parts nickel (II) acetate and Gly-Gly-His tripeptide. Capsids were reacted
for 20hrs at room temperature. Reactions were then quenched using 150mM β-
mercaptoethanol (Sigma-Aldrich) and dialyzed against 1× phosphate buffered saline (1×
PBS). Control reactions without Ni/GGH and MMPP were also setup at room temperature
and treated with β-mercaptoethanol after 20hrs. For electron microscopy, virus preps
(unmodified or crosslinked) were loaded onto a 400 μm mesh carbon-coated copper grid
followed by staining in 2% uranyl acetate. Images were captured using a Zeiss Leo 910 EM
transmission electron microscope.
Western and dot blots
For western blots, crosslinked and control virus (1×1010 vector genomes) were separated on
either NuPAGE 3–8% tris-acetate or 10% Bis/Tris gels (Invitrogen) in 1× tris-acetate or
MOPS running buffer (150V, 1hr). Protein bands were transferred onto nitrocellulose using
1× transfer buffer supplemented with 30% methanol (30V, 1hr). For dot blots (far westerns),
2×109 vector genomes were loaded directly onto a nitrocellulose membrane using a dot blot
apparatus. Western blots were carried out with mouse monoclonal antibodies A1
(recognizing VP1 N-terminal domain), A69 (recognizing VP1/VP2 N-termini), B1
(recognizing VP1/VP2/VP3 C-terminal domain), and A20 (recognizing intact AAV2
capsids) (26) in hybridoma media (diluted 1:30) obtained from the UNC Vector Core and a
goat anti-mouse secondary antibody conjugated to horseradish peroxidase (diluted 1: 5000).
Western bands were visualized using SuperSignal West Femto Sensitivity Substrate
(Thermo Scientific) and were captured using Amersham Hyperfilm ECL film (GE
Healthcare). Western film was developed using a Konica Minolta SRX-101A developer.
In vitro transduction assays
HEK293 cells were seeded at 2×105 cells per well in a 24-well plate format and transduced
18hrs later with different AAV2 vectors packaging the CBA-Luc cassette (MOI = 100).
Transgene expression was determined by luminometric analysis with D-luciferin substrate
(Promega) using a Victor® luminometer (Perkin Elmer) at 18hrs post-infection.
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HeLa cells were seeded on poly-lysine coated coverslips placed in a 24-well plate at 105
cells per well and grown at 37 °C with 5% CO2. After 18hrs, crosslinked or unmodified
virus was added at a multiplicity of infection (MOI) of 50,000 vector genomes per cell. Cells
were fixed with 2% paraformaldehyde, permeabilized with 0.2% Triton X-100, and blocked
with immunofluorescence wash buffer (20 mM Tris pH 7.5, 137 mM NaCl, 3 mM KCl, 1.5
MgCl2, 5mg mL−1 BSA, 0.05% Tween). Following cellular uptake, intact AAV particles
were detected by immunostaining with mouse αCapsid (A20, American Research Products),
while exposed VP1u domains were detected using the rabbit αVP1 (aa 2–16) described
earlier (14). DyLight 488-conjugated goat anti-mouse and DyLight 594-conjugated goat
anti-rabbit secondary antibodies (Pierce Scientific) were utilized for detection by
immunofluorescence. Cells were then mounted with Prolong Gold anti-fade with DAPI®
mounting media (Invitrogen) and imaged using a Zeiss LSM 710 confocal microscope.
Images were captured with parameters including gain, laser power, and offset for each
sample held constant. Analysis of confocal images was carried out after background
correction using ImageJ® software. The mean fluorescence intensity ratio (αVP1u/A20)
represents the fluorescent signal (DyLight 594) arising from exposed VP1u domains
normalized to the fluorescent signal (DyLight 488) that corresponds to the total amount of
internalized AAV2 particles. Histograms of mean fluorescence intensity ratios obtained
from cells (total 30–50 count each) treated with either unmodified or crosslinked AAV2
capsids were then generated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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3D mapping of surface-exposed tyrosines at the two-fold interface on the AAV2 capsid. (A)
Schematic alignment of the three AAV structural proteins VP1, VP2 and VP3 which make
up the capsid. (B) 3D surface model of the AAV2 capsid (PDB ID: 1LP3) containing 60
monomer subunits colored light grey with the icosahedral two-fold (oval), three-fold
(triangle) and five-fold symmetry (pentagon) highlighted in white. Monomer subunits
forming a trimer are colored pale green, wheat and salmon with the neighboring trimer
colored in dark grey. (C) 3D surface model of a dimer of trimers shown in light and dark
grey with corresponding surface-exposed tyrosine residues highlighted in blue and red,
respectively. The two-fold depression is highlighted within the white boxed region showing
a cluster of surface-exposed tyrosine residues. The Tyr704 residue, which extends from one
overlapping capsid protein subunit into the neighboring subunit at the two-fold interface, is
highlighted with white arrows. All images were generated and rendered in PyMol®.
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Site-selective chemical crosslinking of AAV2 capsid subunit dimers. (A) Schematic of
chemical reaction involving treatment of tyrosine side chains with the Ni(II)/GGH complex
to form a dityrosine covalent linkage. (B) Western blot of denatured AAV2 capsid proteins
in unmodified or crosslinked form with the B1 monoclonal antibody (MAb), which detects
the C-terminal domain of all AAV2 VP subunits. Stepwise addition of individual chemical
reagents yielded optimal reaction conditions for crosslinked VP dimer formation. Different
permutations and combinations of VP subunit dimers are labeled based on predicted
molecular weight. Additional dimers are visualized using (C) the A69 MAb, which
recognizes both VP1 and VP2 subunits and (D) the A1 MAb, which recognizes only VP1
subunits. Absolute protein levels of native and crosslinked VP subunits was determined by
SDS-PAGE stained with colloidal blue (E) followed by cross-sectional analysis of the
different lanes with Igor Pro data analysis software (F).
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Tyr-to-Phe mutants reveal molecular mechanisms underlying the formation of crosslinked
VP dimers. Western blots of denatured, wild type (wt) and mutant AAV2 capsid proteins in
unmodified (−) or crosslinked form (+) with B1 (A) and A1 (B) MAbs. (C) Transduction
efficiency (luciferase expression) of unmodified (grey bars) and crosslinked (white bars)
wtAAV2 and Tyr-to-Phe mutants in HEK293 cells (Multiplicity of infection, MOI = 100vg/
cell). Error bars represent standard deviation (n=3). (D) Cartoon of the AAV2 capsid two-
fold interface with neighboring VP subunits colored red and blue. Different tyrosine residues
in each VP subunit are highlighted in the corresponding color. The Y704 residue in one VP
subunit monomer and extends into the neighboring subunit and lies adjacent to the Y730
residue and to a lesser extent the Y700 residue. Distances between the Y704 3′ carbon from
the red monomer and the 3′ carbons for Y730, Y700, and Y704 from the blue monomer are
shown in black. This unique structural arrangement of tyrosines at the two-fold interface is
the driving-force behind dityrosine adduct formation, which yields crosslinked VP subunit
dimers.
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Temperature-dependent exposure of the VP1 N-terminal domain in unmodified (◯) and
crosslinked (●) AAV2 capsids. Unmodified and crosslinked capsids were heated to
different temperatures for 30min prior to dot blot analysis. The intact capsid was detected by
the conformation-specific MAb A20 (A) and MAb A1 (B) was used to detect the exposed
VP1 N-terminal domain. Optical densities were measured using a Kodak® gel
documentation system equipped with an optical filter. Error bars represent standard
deviation (n=3).
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Immunofluorescent confocal micrographs of HeLa cells treated with unmodified (top panel)
or crosslinked (bottom panel) AAV2 capsids (MOI 50,000vg/cell). Images were obtained at
24hrs post-infection with the MAb A20 to detect intact AAV2 capsids (DyLight-488®
green) (A & D) and the MAb αVP1 to detect exposed VP1 N-termini (DyLight-594® red)
(B & E). Image overlay demonstrating co-localized staining of intact capsids with exposed
VP1 N-termini (yellow) is also shown (C & G). Nuclei were stained blue using DAPI. All
images were obtained using a Zeiss LSM 710 confocal fluorescence microscope (Scale =
10μm). Mean fluorescence ratios (αVP1/A20) of individual cells were calculated after
background subtraction. (G) Cells infected with unmodified AAV2 capsids display peak
intensity ratios at 0.1 and 0.4, with nearly 15% of the cells in each subset, suggesting that a
significant population of AAV2 virions contains exposed VP1 N-termini. (n=32). (H) Cells
infected with crosslinked AAV2 capsids display a peak intensity ratio of 0.1 with 30% of the
cells located within this subset, supporting a significant increase in the population of AAV2
capsids defective in externalization of VP1 N-termini (n=46).
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Two models of VP1u exposure during infection. The VP1u domain represented as a black
ribbon drawing was adapted from the structure of porcine pancreatic phospholipase [PDB
ID: 3O4M] and is initially buried within the capsid (A). Tyrosine-crosslinked capsids (B)
are unable to expose their VP1u domain either by preventing opening of the two-fold
symmetry axis (C) or iris-like opening of the five-fold pore (D). VP monomers are
represented as trapezoids in white, light grey or dark grey; the open two-fold axis is
represented as a white oval and five-fold pores are represented as white pentagons.
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